Drawing for Serial No. 79278197

USPTO serial 79278197

Serial No. 79278197

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
COLEMAN, CIMMERIAN
Law office
TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 79278197?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Scientific research, biological research, pharmaceuticals research and development, bacteriological consultations and research, medical and pharmaceutical research services, development of pharmaceutical preparations and medicines, clinical trials and first assessments in the field of new pharmaceuticals, pharmaceutical drug development services, laboratory research services relating to pharmaceuticals, laboratory services relating to the production of monoclonal antibodies, laboratory research services relation to dermatology, calibration services relating to medical devices and equipment, consultancy pertaining to pharmacology, provision of medical and scientific research information in the field of pharmaceuticals and clinical trials, research and development of vaccines and medicines, scientific research for medical purposes in the field of cancerous diseases, scientific research in the field of social medicine, scientific research in the field of pharmacy, services for assessing in the efficiency of veterinary drugs, services for assessing the efficiency of pharmaceutical, research services for regulatory science, product testing services for marketing authorization of medicinal products, scientific research and analysis for pharmacovigilance, audits in pharmacovigilance for assessing the safety of pharmaceuticals, database design and development, electronic data storageACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 8, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 24, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 7, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 7, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 8, 2020MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 8, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 10, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 24, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 23, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 5, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 4, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2020DOCKASSIGNED TO EXAMINER—
Feb 15, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 11, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance